Growth Metrics

Asgn (ASGN) Common Equity (2016 - 2025)

Historic Common Equity for Asgn (ASGN) over the last 16 years, with Q3 2025 value amounting to $1.8 billion.

  • Asgn's Common Equity rose 330.82% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 330.82%. This contributed to the annual value of $1.8 billion for FY2024, which is 609.9% down from last year.
  • As of Q3 2025, Asgn's Common Equity stood at $1.8 billion, which was up 330.82% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Asgn's Common Equity ranged from a high of $1.9 billion in Q2 2023 and a low of $1.6 billion during Q1 2021
  • Its 5-year average for Common Equity is $1.8 billion, with a median of $1.9 billion in 2022.
  • As far as peak fluctuations go, Asgn's Common Equity surged by 2035.17% in 2021, and later plummeted by 703.62% in 2024.
  • Quarter analysis of 5 years shows Asgn's Common Equity stood at $1.9 billion in 2021, then grew by 1.92% to $1.9 billion in 2022, then fell by 0.48% to $1.9 billion in 2023, then decreased by 6.1% to $1.8 billion in 2024, then increased by 3.17% to $1.8 billion in 2025.
  • Its Common Equity stands at $1.8 billion for Q3 2025, versus $1.8 billion for Q2 2025 and $1.8 billion for Q1 2025.